Patents & Licensing

Focusing on the future growth of Vivera’s various divisions, the Company has filed several patent applications for new medical devices, technologies, and pharmaceutical treatments utilizing the TABMELT platform.

Behind the development of each product are years of expertise, research, design, and development focused on bringing the best solutions to the market for patients and their providers.

Vivera has begun laying the groundwork for clinical research trials for a variety of indications, via the Investigational New Drug (IND) and/or New Drug Application (NDA) pathways, to gain FDA approval and globally commercialize its finished pharmaceutical products.

TABMELT BioSciences Patents

Cardiovascular

Jurisdiction Compound Patent Status
United States VVRA – TM 001 Published

Central Nervous System

Jurisdiction Compound Patent Status
United States VVRA – TM 002 Published
United States VVRA – TM 003 Published
United States VVRA – TM 004 Published
United States VVRA – TM 005 Published
United States PTNR – TM 006 Published
United States PTNR – TM 007 Published

Childhood-Onset Fluency Disorder (Stuttering)

Jurisdiction Compound Patent Status
United States VVRA – TM 008 Published

Licensed TABMELT Patents

Jurisdiction Title Patent Status
Australia All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2016
Canada All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2018
United Kingdom All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2018
Russia All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2021
Israel All Natural, Non-Toxic Sublingual Drug Delivery Systems Pending
Japan All Natural, Non-Toxic Sublingual Drug Delivery Systems Pending
Mexico All Natural, Non-Toxic Sublingual Drug Delivery Systems Pending
United States All Natural, Non-Toxic Sublingual Drug Delivery Systems Published

ZICOH Medical Technologies Patents

Jurisdiction Title Patent Status
United States Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Issued, 2021
United States Secure Smart Dosing System With Automated Delivery, Measurement, and Management Issued, 2021
United States Secure Smart Dosing System With Automated Delivery, Measurement, and Management for Pills Allowed
Australia Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Pending
Canada Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Pending
United Kingdom Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Pending
World Intellectual Property Organization Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Published
Australia Secure Smart Dosing System With Automated Delivery, Measurement, and Management Pending
Canada Secure Smart Dosing System With Automated Delivery, Measurement, and Management Pending
Israel Secure Smart Dosing System With Automated Delivery, Measurement, and Management Pending
United Kingdom Secure Smart Dosing System With Automated Delivery, Measurement, and Management Published
World Intellectual Property Organization Secure Smart Dosing System With Automated Delivery, Measurement, and Management Published
World Intellectual Property Organization Secure Smart Dosing System With Automated Delivery, Measurement, and Management for Pills Pending

Medical Technologies Patents

Jurisdiction Title Patent Status
United States Neurosciences Medical Device Software Pending
United States Self-Administered Infection Testing and Result Determination Published
United States Self-Contained, Portable Sanitation Device and Telemedicine Station Pending

Indication Schedule